Brain Fog in ME/CFS Linked to Waste Clearance Issues

Brain Fog in ME/CFS Linked to Waste Clearance Issues

Researchers at Griffith University have discovered that the brain’s natural waste clearance system is impaired in individuals living with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This dysfunction may provide a mechanistic explanation for the cognitive impairment known as brain fog and other inflammatory changes associated with the condition.

The waste clearance process is managed by the glymphatic system, a lymphatic analog of the brain. This system is primarily active during sleep and disengaged while a person is awake, flushing out toxic metabolic waste products — such as glutamate, lactate, ammonia, reactive oxygen species, and protein aggregates like tau and $\beta$-amyloid — to maintain brain homeostasis.

According to Dr. Kiran Thapaliya, lead author from Griffith’s National Centre for Neuroimmunology and Emerging Diseases (NCNED), the study is the first to use MRI to demonstrate impaired glymphatic function in ME/CFS. Thapaliya stated that when this system fails to work properly, harmful waste can build up, which may cause neuroinflammation. He suggested that this dysfunction may be a key driver of this condition.

The Role of Sleep and AQP4 Channels

The research highlights a bidirectional relationship between sleep and brain health. Professor Sonya Marshall-Gradisnik, NCNED Director, noted that reduced glymphatic function causes both brain fog and sleep disturbance. She added that the study found poor brain waste clearance is associated with worse sleep.

At the cellular level, the glymphatic system relies on astrocytes, housekeeping cells that maintain neuronal homeostasis. These cells possess end-feet processes containing aquaporin-4 (AQP4) water channels, which regulate fluid balance across the blood-brain barrier and facilitate the flow of cerebrospinal fluid. In healthy brains, AQP4 has a polarized distribution, meaning it is highly concentrated in the astrocyte end-feet to ensure efficient waste removal.

However, various factors can disrupt this process:

• Oxidative Stress: High levels of reactive oxygen species (ROS) can cause lipid peroxidation, damaging astrocyte membranes and leading to AQP4 depolarization.
• Blood Flow: Reduced cerebral blood flow can lead to hypoxia, which impairs the glymphatic system.
• Autoimmunity: There is a hypothesis that anti-AQP4 autoantibodies may target these components, similar to what is observed in neuromyelitis optica.
• Adrenergic Dysfunction: Chronic high levels of norepinephrine may interfere with how AQP4 is regulated.

Connecting "Brain Fog" to Biology

While patients often use the term brain fog, clinical research indicates it is a profound neurological impairment.

This cognitive dysfunction is closely tied to post-exertional malaise (PEM), where mental exertion can trigger a systemic crash. Because the brain consumes roughly 20% of the body's total energy, cognitive work can mimic the metabolic stress of intense physical exercise in patients with impaired cellular machinery.

The accumulation of metabolic waste due to glymphatic dysfunction can trigger a cascade of events, including the activation of the NLRP3 inflammasome in microglia, which further exacerbates neuroinflammation and cognitive lethargy.

Pathways Toward Diagnosis and Treatment

ME/CFS is defined by the World Health Organization as a neurological disorder, yet an estimated 90% of patients remain undiagnosed due to a lack of simple diagnostic tests. Professor Marshall-Gradisnik expressed hope that these results will pave the way for better diagnosis through non-invasive procedures and future treatments.

By targeting the glymphatic system and promoting efficient waste clearance, researchers aim to address the root cause of neurological dysfunction and alleviate the cognitive symptoms that often prevent patients from returning to their personal and social roles.